Darren Smith
Förmögenhet: 153 022 $ per 2026-09-30
Förmögenhet: 153 022 $ per 2026-09-30
Darren Smith is currently Director at Telix QSAM, Inc., Co-Managing Director at Rhine Pharma GmbH, Member at the Australian Institute of Co. Directors, and Group Chief Financial Officer at Telix Pharmaceuticals Ltd. since 2022.
Formerly, Mr. Smith was Global Chief Financial Officer & Secretary at Sirtex Medical Pty Ltd. from 2009 to 2019.
Education includes an undergraduate degree from the University of Western Sydney and an MBA from the Australian Graduate School of Management.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-09-07 | 13 992 ( 0 % ) | 153 022 $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Finansdirektör/CFO | 2022-07-31 |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Företagsledare/Principal | - |
| Företag | Position | Slut |
|---|---|---|
| SIRTEX MEDICAL LIMITED | Finansdirektör/CFO | 2019-03-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Sirtex Medical Pty Ltd.
Sirtex Medical Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of treatment for liver cancer | Commercial Services |
University of Western Sydney
University of Western Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Australian Graduate School of Management
Australian Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån